Biotechnology is a vast discipline where integrated technology derived from modern biology is applied to the areas from consumer products, the environment to medicine. Biomedical Science is centered upon the specific application of biology in medicine to the areas of diagnostics and therapeutics.

Yes. Farmers have embraced crops enhanced through biotechnology because they provide value and solve real, sometimes previously intractable, problems. U.S. farmers, in particular, have taken advantage of this new technology. USDA has estimated that in 2004, 45 percent of the corn (36.4 million acres), 76 percent of the cotton (10.4 million acres), and 85 percent of the soybeans (63.5 million acres) planted were biotech varieties.

Agricultural biotechnology is an advanced technology that allows plant breeders to make precise genetic changes to impart beneficial traits to the crop plants we rely on for food and fiber. For centuries farmers and plant breeders have labored to improve crop plants. Traditional breeding methods include selecting and sowing the seeds from the strongest, most desirable plants to produce the next generation of crops.

Biotechnology is the application of scientific information and methods to biological problems such as in agriculture and medicine. It includes moving traits or characteristics from one organism to another, to improve or create new industrial, medical and agricultural products.

More information on Biotechnology and U.S. trade is available at http://www.fas.usda.gov/itp/biotech/index.html.

Yes, the Diploma in Biotechnology could prepare you for a career in forensic science. You can pursue a degree programme in forensic science since this course covers molecular biology, plant and animal cells, biochemistry, analytical biochemistry, pathology, biology, chemistry and other relevant subjects.

Old techniques: selective breeding and crossbreeding. These concentrate on choosing visible traits and consciously trying to recreate these in later generations. New techniques: recombinant DNA and genetic engineering; these use more recently designed molecular tools to transfer specific genes into a developing plant. Unlike the older techniques, most scientists will be able to predict exactly what change this will produce in a plant.

Only fools and small-minded people would oppose research on something so wonderful-even if there were only a 10% chance that it was correct (and the true percentage is far higher -100%, in our opinion). Sad to say, there are plenty of fools arrayed against New Energy. Most of them are in academia and in government agencies charged with managing scientific research-though there are outstanding exceptions.

For almost 14 years now-the time since the Fleischmann-Pons announcement- we have observed a very strange phenomenon. Those who one might expect would have the greatest interest in and enthusiasm for New Energy, show no interest in it at all - in fact provably (it has been brought to their attention) they deliberately ignore it.

It all comes down to beliefs, and often a deep inner knowing. It involves intuition and trust. It involves listening. It involves a whole lot of things that are currently beyond the scope of accepted scientific thinking. The important thing to remember is that new age beliefs don't reject science. Modern science has brought tremendous good to our society in many ways. New age beliefs simply expand beyond accepted thinking in the exploration and search for life's eternal truths.

By providing the tools to assemble and explore massive data sets quickly, the NVO will facilitate and enable a broad range of science. It will make practical studies which otherwise would require so much time and resources that they would be effectively impossible. Federating massive data sets over a broad range of wavelengths, spatial scales, and temporal intervals may be especially fruitful.

Yes. The U.S. regulatory system, which enjoys a high degree of public confidence, employs rigorous scientific reviews within a transparent decision-making framework open to public participation. This regulatory approach provides full access to documents on which decisions are based and is carried out completely in the public eye as required by law. The science-based U.S. regulatory system has helped ensure that biotechnology products are safe for producers, consumers, and the environment.